We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Jemperli (dostarlimab-gxly), a targeted therapy for endometrial cancer and dMMR solid tumors. Understand its dosage, administration, strength, and treatment duration.

Jemperli, with the active ingredient dostarlimab-gxly, is a targeted therapy medication prescribed for adults battling specific types of cancer. It is particularly used for endometrial cancer and solid tumors that are mismatch repair deficient (dMMR). This condition arises when cancer cells have genetic mutations that hinder their ability to correct errors during cell replication, increasing the risk of cancer development. Jemperli is often considered when the cancer has spread or recurred after previous treatments, and in some instances, it is administered alongside chemotherapy.
Jemperli is a biologic drug, meaning it is derived from living cells. It functions as a type of targeted therapy, specifically identifying and acting upon genetic mutations within cancer cells. The active ingredient, dostarlimab-gxly, targets these mutations, aiming to disrupt the cancer's growth and spread. The suffix '-gxly' is a unique identifier for this specific biologic drug.
Jemperli is administered intravenously (IV) by a healthcare professional. It is supplied as a liquid solution in a single-dose vial. Before administration, the small volume of liquid from the vial is diluted in a larger volume of saline solution. The infusion typically takes about 30 minutes.
Jemperli is available in a strength of 500 milligrams (mg) of the drug per 10 milliliters (mL) of liquid solution.
The dosage of Jemperli is determined by your doctor based on the specific condition being treated. The general recommendations are:
Your doctor will inform you about the exact amount and frequency of Jemperli you will receive. The typical Jemperli dosage for adults is administered once every 3 or 6 weeks, depending on the treatment plan.
Several factors can influence the dosage of Jemperli prescribed to a patient:
Jemperli is often used as a long-term treatment. If your doctor determines that it is safe and effective for your condition, you may continue Jemperli treatment for an extended period.
Jemperli infusions are administered at your doctor's office or a clinic. It is crucial to attend all scheduled appointments for treatment.
If you miss an appointment for your Jemperli infusion, contact your doctor's office immediately to reschedule. If you have trouble remembering appointments, consider setting reminders on your phone or using a calendar alert system.
Always discuss any concerns or questions about your Jemperli treatment with your healthcare provider. They are the best resource for personalized medical advice regarding your condition and treatment plan.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026